Literature DB >> 7706244

Roles for a cytoplasmic tyrosine and tyrosine kinase activity in the interactions of Neu receptors with coated pits.

L Gilboa1, R Ben-Levy, Y Yarden, Y I Henis.   

Abstract

The neu proto-oncogene product, p185neu (HER2, c-ErbB-2), encodes a cell-surface tyrosine kinase receptor with high oncogenic potential, which correlates with increased tyrosine kinase activity and a rapid receptor internalization rate. To investigate the interactions and signal(s) leading to the endocytosis of Neu receptors, we employed lateral mobility and internalization studies. Fluorescence photobleaching recovery measurements revealed that activation of Neu receptors (induced by mutation or by agonistic antibodies) markedly reduced their mobile fractions. To elucidate the signals involved, other mutants, all carrying a constitutively dimerizing oncogenic mutation, were analyzed. A kinase-negative mutant and a mutant lacking all cytoplasmic tyrosine phosphorylation consensus sequences exhibited high mobile fractions, similar to nonactivated Neu. Retention of a single tyrosine autophosphorylation site (Tyr-1253) out of the five known such sites was sufficient to immobilize a large fraction of the receptor. For all mutants, internalization correlated with receptor immobilization and was blocked by treatments that interfere with coated pit structure, indicating that the immobilization is due to interactions with coated pits. This was supported by the coimmunoprecipitation of alpha-adaptin only with the constitutively activated Neu mutants. We conclude that activated Neu receptors become stably associated with coated pits via plasma membrane adaptor complexes (AP-2). Efficient Neu receptor endocytosis requires activation, a functional kinase domain, and at least one tyrosine autophosphorylation site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706244     DOI: 10.1074/jbc.270.13.7061

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Characterization of the mouse beta-prime adaptin gene; cDNA sequence, genomic structure, and chromosomal localization.

Authors:  C Guilbaud; M Peyrard; I Fransson; S W Clifton; B A Roe; N P Carter; J P Dumanski
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

2.  Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis.

Authors:  A Nesterov; R E Carter; T Sorkina; G N Gill; A Sorkin
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.

Authors:  Anette M Hommelgaard; Mads Lerdrup; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

4.  Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons.

Authors:  Yu Liu; Yan-Mei Tao; Ran-Sook Woo; Wen-Cheng Xiong; Lin Mei
Journal:  Biochem Biophys Res Commun       Date:  2007-01-10       Impact factor: 3.575

5.  Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes.

Authors:  W Boll; H Ohno; Z Songyang; I Rapoport; L C Cantley; J S Bonifacino; T Kirchhausen
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

6.  Regulatory interactions in the recognition of endocytic sorting signals by AP-2 complexes.

Authors:  I Rapoport; M Miyazaki; W Boll; B Duckworth; L C Cantley; S Shoelson; T Kirchhausen
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

7.  AP-3: an adaptor-like protein complex with ubiquitous expression.

Authors:  E C Dell'Angelica; H Ohno; C E Ooi; E Rabinovich; K W Roche; J S Bonifacino
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

8.  Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers.

Authors:  Rajasree Menon; Gilbert S Omenn
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

9.  Ligand-induced endocytosis of epidermal growth factor receptors that are defective in binding adaptor proteins.

Authors:  A Nesterov; H S Wiley; G N Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

Review 10.  The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Authors:  Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey Drebin; Izumi Nagatomo; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-05-18       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.